These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34960238)

  • 1. A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses.
    Oreshkova N; Myeni SK; Mishra N; Albulescu IC; Dalebout TJ; Snijder EJ; Bredenbeek PJ; Dallmeier K; Kikkert M
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models.
    Ma J; Yakass MB; Jansen S; Malengier-Devlies B; Van Looveren D; Sanchez-Felipe L; Vercruysse T; Weynand B; Javarappa MPA; Quaye O; Matthys P; Roskams T; Neyts J; Thibaut HJ; Dallmeier K
    EBioMedicine; 2022 Sep; 83():104240. PubMed ID: 36041265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The yellow fever 17D virus as a platform for new live attenuated vaccines.
    Bonaldo MC; Sequeira PC; Galler R
    Hum Vaccin Immunother; 2014; 10(5):1256-65. PubMed ID: 24553128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
    Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.
    Ma J; Boudewijns R; Sanchez-Felipe L; Mishra N; Vercruysse T; Buh Kum D; Thibaut HJ; Neyts J; Dallmeier K
    Emerg Microbes Infect; 2021 Dec; 10(1):2279-2290. PubMed ID: 34792431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon.
    Nakamura A; Kotaki T; Nagai Y; Takazawa S; Tokunaga K; Kameoka M
    PLoS One; 2022; 17(10):e0274829. PubMed ID: 36264936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YF17D-based vaccines - standing on the shoulders of a giant.
    Sanchez-Felipe L; Alpizar YA; Ma J; Coelmont L; Dallmeier K
    Eur J Immunol; 2024 May; 54(5):e2250133. PubMed ID: 38571392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques--implications for recombinant vaccine design.
    Mudd PA; Piaskowski SM; Neves PC; Rudersdorf R; Kolar HL; Eernisse CM; Weisgrau KL; de Santana MG; Wilson NA; Bonaldo MC; Galler R; Rakasz EG; Watkins DI
    Immunogenetics; 2010 Sep; 62(9):593-600. PubMed ID: 20607226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.
    Sanchez-Felipe L; Vercruysse T; Sharma S; Ma J; Lemmens V; Van Looveren D; Arkalagud Javarappa MP; Boudewijns R; Malengier-Devlies B; Liesenborghs L; Kaptein SJF; De Keyzer C; Bervoets L; Debaveye S; Rasulova M; Seldeslachts L; Li LH; Jansen S; Yakass MB; Verstrepen BE; Böszörményi KP; Kiemenyi-Kayere G; van Driel N; Quaye O; Zhang X; Ter Horst S; Mishra N; Deboutte W; Matthijnssens J; Coelmont L; Vandermeulen C; Heylen E; Vergote V; Schols D; Wang Z; Bogers W; Kuiken T; Verschoor E; Cawthorne C; Van Laere K; Opdenakker G; Vande Velde G; Weynand B; Teuwen DE; Matthys P; Neyts J; Jan Thibaut H; Dallmeier K
    Nature; 2021 Feb; 590(7845):320-325. PubMed ID: 33260195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of yellow fever virus infection in mice using a bioluminescent reporter virus.
    Dong HL; Wang HJ; Liu ZY; Ye Q; Qin XL; Li D; Deng YQ; Jiang T; Li XF; Qin CF
    Emerg Microbes Infect; 2021 Dec; 10(1):1739-1750. PubMed ID: 34379047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.
    Li LH; Liesenborghs L; Wang L; Lox M; Yakass MB; Jansen S; Rosales Rosas AL; Zhang X; Thibaut HJ; Teuwen D; Neyts J; Delang L; Dallmeier K
    Mol Ther Methods Clin Dev; 2022 Jun; 25():215-224. PubMed ID: 35313504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
    Gutiérrez-Álvarez J; Honrubia JM; Sanz-Bravo A; González-Miranda E; Fernández-Delgado R; Rejas MT; Zúñiga S; Sola I; Enjuanes L
    Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34686605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
    Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
    J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism.
    Wang HJ; Guo Y; He MJ; Liu ZY; Ye Q; Huang XY; Deng YQ; Li XF; Qin CF
    Microbiol Spectr; 2022 Oct; 10(5):e0224622. PubMed ID: 35980184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
    Agnihothram S; Yount BL; Donaldson EF; Huynh J; Menachery VD; Gralinski LE; Graham RL; Becker MM; Tomar S; Scobey TD; Osswald HL; Whitmore A; Gopal R; Ghosh AK; Mesecar A; Zambon M; Heise M; Denison MR; Baric RS
    mBio; 2014 Mar; 5(2):e00047-14. PubMed ID: 24667706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses.
    Agnihothram S; Gopal R; Yount BL; Donaldson EF; Menachery VD; Graham RL; Scobey TD; Gralinski LE; Denison MR; Zambon M; Baric RS
    J Infect Dis; 2014 Apr; 209(7):995-1006. PubMed ID: 24253287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
    Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
    J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.